Pinnacle Wealth Planning Services’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Pinnacle Wealth Planning Services's JAZZ Position: Q2 2026 in Review
Pinnacle Wealth Planning Services increased its Jazz Pharmaceuticals (JAZZ) stake by 1.2% in Q2 2026, buying an estimated $4.38K and bringing the position to 1,637 shares worth $394K. The position accounts for 0.04% of the portfolio, ranked #276.
Pinnacle Wealth Planning Services first reported a position in JAZZ in Q4 2020 and has held it in 5 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Pinnacle Wealth Planning Services held 1,637 shares of Jazz Pharmaceuticals worth $394K as of Q2 2026.
- Pinnacle Wealth Planning Services bought 20 Jazz Pharmaceuticals shares in Q2 2026, an estimated $4.38K.
- Jazz Pharmaceuticals made up 0.04% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #276 holding.
- Pinnacle Wealth Planning Services first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 5 quarters since.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.